142 related articles for article (PubMed ID: 30122956)
1. Relationship of
Zhang S; Jiang J; Chen Z; Wang Y; Tang W; Chen Y; Liu L
Onco Targets Ther; 2018; 11():4651-4660. PubMed ID: 30122956
[TBL] [Abstract][Full Text] [Related]
2.
Lin J; Chen Y; Tang WF; Liu C; Zhang S; Guo ZQ; Chen G; Zheng XW
Front Oncol; 2019; 9():63. PubMed ID: 30838172
[No Abstract] [Full Text] [Related]
3. PPARGC1A rs3736265 G>A polymorphism is associated with decreased risk of type 2 diabetes mellitus and fasting plasma glucose level.
Zhu L; Huang Q; Xie Z; Kang M; Ding H; Chen B; Chen Y; Liu C; Wang Y; Tang W
Oncotarget; 2017 Jun; 8(23):37308-37320. PubMed ID: 28418876
[TBL] [Abstract][Full Text] [Related]
4. Association between PPARĪ³, PPARGC1A, and PPARGC1B genetic variants and susceptibility of gastric cancer in an Eastern Chinese population.
Chen B; Wang Y; Tang W; Chen Y; Liu C; Kang M; Xie J
BMC Med Genomics; 2022 Dec; 15(1):274. PubMed ID: 36587194
[TBL] [Abstract][Full Text] [Related]
5. The relationship between
Qiu H; Wang Y; Kang M; Ding H; Liu C; Tang W; Xiao Z; Chen Y
Onco Targets Ther; 2017; 10():5525-5532. PubMed ID: 29200867
[TBL] [Abstract][Full Text] [Related]
6. Association between
Wang YZ; Zhang HY; Liu F; Li L; Deng SM; He ZY
Neural Regen Res; 2019 Nov; 14(11):1986-1993. PubMed ID: 31290457
[TBL] [Abstract][Full Text] [Related]
7. Assessment of
Chen Z; Wang Y; Wang J; Kang M; Tang W; Chen S
DNA Cell Biol; 2020 Sep; 39(9):1521-1531. PubMed ID: 32721231
[TBL] [Abstract][Full Text] [Related]
8. Association of
Jiang J; Xie Z; Guo J; Wang Y; Liu C; Zhang S; Tang W; Chen Y
Oncotarget; 2017 Nov; 8(59):100558-100569. PubMed ID: 29246001
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor gamma (PPARG) polymorphisms and breast cancer susceptibility: a meta-analysis.
Tang W; Chen Y; Wang Y; Gu H; Chen S; Kang M
Int J Clin Exp Med; 2015; 8(8):12226-38. PubMed ID: 26550133
[TBL] [Abstract][Full Text] [Related]
10. TNIP1 Polymorphisms with the Risk of Hepatocellular Carcinoma Based on Chronic Hepatitis B Infection in Chinese Han Population.
Cheng Y; Jiang X; Jin J; Luo X; Chen W; Li Q; Zhang C
Biochem Genet; 2019 Feb; 57(1):117-128. PubMed ID: 30073579
[TBL] [Abstract][Full Text] [Related]
11. Investigation of
Yang J; Liu J; Chen Y; Tang W; Bo K; Sun Y; Chen J
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31235485
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma rs1801282 C>G polymorphism is associated with polycystic ovary syndrome susceptibility: a meta-analysis involving 7,069 subjects.
Zhang S; Wang Y; Jiang H; Liu C; Sun B; Chen S; Kang M; Tang W
Int J Clin Exp Med; 2015; 8(10):17418-29. PubMed ID: 26770332
[TBL] [Abstract][Full Text] [Related]
13. Relationship between
Chen S; Qiu H; Liu C; Wang Y; Tang W; Kang M
Cancer Manag Res; 2018; 10():2965-2975. PubMed ID: 30214291
[TBL] [Abstract][Full Text] [Related]
14. Investigation of
Zhang S; Jiang J; Chen Z; Wang Y; Tang W; Liu C; Liu L; Chen Y
Onco Targets Ther; 2018; 11():2083-2089. PubMed ID: 29695916
[TBL] [Abstract][Full Text] [Related]
15. Effects of
Muntean C; Sasaran MO; Crisan A; Banescu C
Front Public Health; 2022; 10():962852. PubMed ID: 36466447
[TBL] [Abstract][Full Text] [Related]
16. PPARG c.1347C>T polymorphism is associated with cancer susceptibility: from a case-control study to a meta-analysis.
Ding H; Chen Y; Qiu H; Liu C; Wang Y; Kang M; Tang W
Oncotarget; 2017 Nov; 8(60):102277-102290. PubMed ID: 29254243
[TBL] [Abstract][Full Text] [Related]
17. [Association between miR-146a single nucleotide polymorphism and genetic susceptibility to hepatocellular carcinoma: a meta-analysis].
Zhang LH; Zhang CY; Dai XZ; Zhang J; Zhang F
Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):749-754. PubMed ID: 29108203
[No Abstract] [Full Text] [Related]
18. Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinoma.
Nan YL; Hu YL; Liu ZK; Duan FF; Xu Y; Li S; Li T; Chen DF; Zeng XY
World J Gastroenterol; 2016 Jun; 22(24):5558-67. PubMed ID: 27350734
[TBL] [Abstract][Full Text] [Related]
19. IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
Li N; Zhu Q; Li Z; Han Q; Zhang G; Chen J; Lv Y; Xing F; Chen Y; Zeng X; Liu Z
Mol Carcinog; 2014 Jun; 53(6):447-57. PubMed ID: 23280722
[TBL] [Abstract][Full Text] [Related]
20. MiR-146a and miR-196a-2 polymorphisms are associated with hepatitis virus-related hepatocellular cancer risk: a meta-analysis.
Tian T; Wang M; Zhu W; Dai ZM; Lin S; Yang PT; Liu XH; Liu K; Zhu YY; Zheng Y; Liu M; Dai ZJ
Aging (Albany NY); 2017 Jan; 9(2):381-392. PubMed ID: 28148887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
